Chapter
A New Funding Model for Biotech Startups
25:49 - 29:06 (03:16)
This episode discusses a new funding model for biotech startups that attracts money from conservative investors and de-risks the investment. The host discusses how this model allows for bigger investments from a wider range of investors, potentially leading to more innovation in the industry.
Clips
A new funding model is de-risking biotech investments for conservative investors, enabling the industry to attract more money from sources such as pensions and insurance firms, rather than just venture capitalists.
25:49 - 29:06 (03:16)
Biotechnology
Summary
A new funding model is de-risking biotech investments for conservative investors, enabling the industry to attract more money from sources such as pensions and insurance firms, rather than just venture capitalists. The model is the brainchild of Kevin Pojasek, founder of True North Therapeutics, who plans to use the model to fund 150 startups researching 150 different diseases.